Tower Research Capital LLC (Trc) Pardes Biosciences, Inc. Transaction History

Tower Research Capital LLC (Trc)

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 09, 2023	BUY	$1.21 - $2.22 $2,532 - $4,646	2,093 Added 31.78%	8,678 $11,000
Q4 2022 Feb 10, 2023	BUY	$0.85 - $1.69 $796 - $1,583	937 Added 16.59%	6,585 $11,000
Q3 2022 Nov 10, 2022	SELL	$2.14 - $3.7 $4,491 - $7,766	-2,099 Reduced 27.09%	5,648 $10,000
Q2 2022 Aug 15, 2022	BUY	$2.84 - $8.57 $18,045 - $54,453	6,354 Added 456.14%	7,747 $23,000
Q1 2022 May 12, 2022	BUY	$5.64 - $15.64 $6,271 - $17,391	1,112 Added 395.73%	1,393 $10,000

Q4 2021 Feb 14, 2022	BUY	$9.8 - $17.02 $2,753 - $4,782	281 New	281 $5,000

5.23M

Ticker PRDS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,320,900
Description
Pardes Biosciences, Inc., a clinical stage biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics to improve the lives of patients suffering from life-threatening disease. Its lead candidate is the PBI-0451 that is in clinical development stage to treat and prevent severe acute respiratory syndrome ...

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.